City
Washington, D.C.
1,021 announced deals involving Washington, D.C., most recent first, with the firms that advised on each.
Most recent
SEARCH ALL 1,021 Clifford Chance advises IDB Invest on US$100 million A/B loan to Vientos Bonaerenses S.A. 3 Nov 2026
Latham & Watkins Advises Vistra on Completed Acquisition of Cogentrix Natural Gas Portfolio 3 Nov 2026
Latham & Watkins Advises Pelthos Therapeutics in Combination With Castle Creek Biosciences 3 Nov 2026
Latham & Watkins Advises DoorDash on US$17 Billion Acquisition of Instacart 3 Nov 2026
Latham & Watkins Advises Platinum Equity in Acquisition of Energy Distribution Partners 29 Oct 2026
Latham & Watkins Advises Triton on Sale of Trench to GE Vernova 29 Oct 2026
Latham Advises Jio Platforms on INR 301,876 Million (US$3.2 Billion) IPO 29 Oct 2026
Latham Advises Advent on Its Investment in Firehawk 29 Oct 2026
Linklaters advises thyssenkrupp on the spin-off and listing of tk accelis 29 Oct 2026
Clifford Chance advises CAF on A/B Loan to Pan American Energy, S.L., Sucursal Argentina 28 Oct 2026
Clifford Chance advises CICC on landmark three-way merger with Dongxing Securities and Cinda Securities 28 Oct 2026
Latham Advises CoStar Group in US$730 Million Acquisition of Vexcel 28 Oct 2026
Latham Advises Guidewire on Acquisition of hyperexponential 28 Oct 2026
Latham & Watkins Advises LSEG on US$3.535 Billion Acquisition of Octus 27 Oct 2026
Latham & Watkins Advises Arcus Biosciences on US$250 Million Public Offering of Common Stock 27 Oct 2026
Latham Advises on Smith & Wesson’s Acquisition of Savage Arms 22 Oct 2026
DLA Piper advises Arlington Capital Partners and Everest Clinical Research on acquisition of Firma Clinical Research unit 21 Oct 2026
Latham & Watkins Advises Melange Capital Partners as Lead Investor in EnCap’s US$3.5 Billion Minerals Continuation Vehicle 21 Oct 2026
Latham & Watkins Advises Morgan Stanley Capital Partners on Acquisition of The Rapid Group 21 Oct 2026
Latham & Watkins Advises Trumid in US$1.97 Billion Acquisition by Tradeweb 21 Oct 2026
TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (Nasdaq: TCGX), a special purpose acquisition company (SPAC) sponsored by TCGX, have announced the execution of a definitive business combination agreement that will result in TriGemX Bio becoming a publicly traded company. The combined company will be named TriGemX Bio, Inc. and is expected to trade on Nasdaq under the new ticker symbol TGEM. Latham & Watkins LLP represents TCGX in the transaction with a corporate team led by Houston partners Ryan Maierson and Ryan Lynch, with associates Taylor Allison, Cooper Shear, and Luisa Gomez Yokubaitis, with assistance from Zachary Mouton. Advice was also provided on tax matters by Houston partner Jared Grimley, with associates Dominick Constantino and Graham Core; on benefits matters by Los Angeles partner Michelle Carpenter, with associate Jordan Barnes; on healthcare regulatory matters by Washington, D.C. partner Nathan Beaton and counsel Nicole Liffrig Molife and Chad Jennings, with associate Margaret Rote; on funds matters by Chicago partner David Moore and New York partner Jennifer Tian;* on data cybersecurity matters by New York partner Jessica Cohen, with associates Laura Geraci and Nat Lewis; on data privacy and cybersecurity matters by Bay Area partner Heather Deixler, with associate Ryleigh Chen; on environmental matters by Los Angeles/Houston partner Joshua Marnitz, with associate Brandon Kerns; on anti-bribery and anti-money laundering matters by Washington, D.C. partner Daniel Dominguez, with associates Patricia Amselem Bensadon and Ai Ni Lim; on antitrust matters by Washington, D.C. partner Jason Cruise and Washington, D.C. counsel Ngoc Hulbig; and on economic sanctions and export controls matters by Washington, D.C. partner Eric Volkman, with associate Amulya Vadapalli. *Admitted to practice in Illinois only. 21 Oct 2026
Latham Advises The Sterling Group on Partnership With United Window & Door Manufacturing 21 Oct 2026
DLA Piper advises POSCO International on US$550 million agreement to acquire Chord’s Marcellus gas assets 19 Oct 2026
Clifford Chance advises Banco de Occidente on US$150 million subordinated facility to strengthen its Tier 2 capital 19 Oct 2026
Latham & Watkins Advises Zocdoc on Acquisition of Sohar Health 19 Oct 2026
Latham & Watkins Advises The Knot Worldwide in Agreement Adding Zola to Global Brand Portfolio 19 Oct 2026
Latham & Watkins Advises Icon on US$200 Million Series D Financing 14 Oct 2026
Latham & Watkins Advises Magnite on Successful Completion of Term Loan and Revolving Credit Facility Repricing 14 Oct 2026
Latham & Watkins Advises on Grain Management’s Definitive Agreement to Sell Nationwide 800 MHz Spectrum Portfolio to SpaceX 12 Oct 2026
Latham Represents Crescent Energy on Its Net US$3.85 Billion Acquisition of Devon Energy’s Eagle Ford Assets 9 Oct 2026
Latham Advises UL Solutions on Acquisition of Eurofins Scientific’s Electrical & Electronics Business 9 Oct 2026
Hogan Lovells Cadwalader advises Rice University as it launches One Giant Leap Ventures, backing startups across the university ecosystem 8 Oct 2026
Clifford Chance advises Banconal on US$500 million A/B loan to finance SMEs and the agricultural sector in Panama 8 Oct 2026
Latham Advises on Vaxcyte’s Concurrent Public Offerings of Common Stock, Pre-Funded Warrants, and Convertible Senior Notes 8 Oct 2026
Latham & Watkins Advises The Sterling Group Foundation Fund on Acquisition of Slingmax Group 8 Oct 2026
Latham & Watkins Represents OIC on Credit Income Strategy Launch With Liberty Mutual Investments 8 Oct 2026
Mayer Brown advises Prescient Security on the sale of a majority stake to SGS. 7 Oct 2026
Mayer Brown advises PSP Partners on the sale of StormTrap to Advanced Drainage Systems. 7 Oct 2026
Latham & Watkins Advises ECP on US$834 Million Continuation Vehicle for Next Wave Energy Partners 6 Oct 2026
Latham & Watkins Advises Charlesbank in Completed Merger of Spectrotel and AireSpring 6 Oct 2026
Latham & Watkins Advises Tactacam on Completed Acquisition by GTCR 1 Oct 2026
Latham & Watkins Advises Long Lake in Completed US$6.3 Billion Acquisition of American Express Global Business Travel September 30, 2 1 Oct 2026
Latham & Watkins Advises the Initial Purchasers in connection with PRA Group’s US$400 Million Senior Notes Offering 1 Oct 2026
Hogan Lovells Cadwalader advises Brixmor Property Group in pending acquisition of Slate Grocery in US$2.34 billion REIT deal 30 Sept 2026
Hogan Lovells Cadwalader advises Ligand on financing agreement with AvenCell Therapeutics 30 Sept 2026
Latham Advises Shenzhen Kinwong Electronic on HK$5.1 Billion IPO 30 Sept 2026
Latham Advises on RoboTechnik’s HK$5.18 Billion IPO 30 Sept 2026
Latham Advises Clifford Capital on US$802.4 Million Infrastructure Asset-Backed Securities Issuance 30 Sept 2026
Latham & Watkins Advises AMD on US$8.2 Billion Acquisition of World Labs 30 Sept 2026
Latham & Watkins Advises on SoftBank Group’s Record-Breaking US$11.1 Billion Bond Offering 29 Sept 2026
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering 28 Sept 2026
Clifford Chance advises on US$209 million senior secured refinancing for Ransa group 28 Sept 2026
Hogan Lovells Cadwalader advises IBM on its acquisition of Logiq Consulting 25 Sept 2026
Latham & Watkins Advises Life Science Intelligence on Strategic Partnership With Opus Origin 25 Sept 2026
Latham Advises National Stock Exchange of India Limited on US$2.36 Billion IPO 25 Sept 2026
Baker McKenzie Advises Bayer on the Sale of Cancer Treatment Stivarga® to Grünenthal 24 Sept 2026
Latham & Watkins Represents Sandals Resorts in Landmark Partnership With Royal Caribbean 24 Sept 2026
Latham & Watkins Advises Flexpoint Ford in Acquisition of Podium Entertainment 24 Sept 2026
Latham Advises on Ligent Technologies’ HK$5.67 Billion IPO 24 Sept 2026
Baker McKenzie Advises GeoPark on Strategic Entry into Venezuela’s Bare Block 21 Sept 2026